1National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing.Pennsylvania:NCCLS,2002.M100-S12.
2Statement 1996 CA-SFM Zone sizes and MIC breakpoints for non-fastidious organisms.Clin Microbiol Infect,1996,2 Suppl 1:S46.
3Morosini MI,Canton R,Loza E,et al.In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.Antimicrob Agents Chemother,2001,45:2427-2431.
4Sutcliffe J,Grebe T,Tait-Kamradt A,et al.Detection of erythromycin-resistant determinants by PCR.Antimicrob Agents Chemother,1996,40:2562-2566.
5Kataja J,Huovinen P,Skurnik M,et al.Erythromycin resistance genes in group A streptococci in Finland.The Finnish Study Group for Antimicrobial Resistance.Antimicrob Agents Chemother,1999,43:48-52.
6Granizo JJ,Aguilar L,Casal J,et al.Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997).J Antimicrob Chemother,2000,46:767-773.
7Nishijima T,Saito Y,Aoki A,et al.Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics.J Antimicrob Chemother,1999,43:637-643.
